Epidemiology of cervical cancer in India: Where do we stand today

Slides:



Advertisements
Similar presentations
Cancer cases and deaths across the world and in the UK : October 2011 Incidence across regions There are big variations in cancer incidence across the.
Advertisements

1 肿瘤防治科 Dept. of Cancer Ctr. & Prevention Pattern of the Incidence of Thyroid Cancer before and after Universal Salt Iodization in Shanghai Ying ZhengMD,
1 Global AIDS Epidemic The first AIDS case was diagnosed in years later, 20 million people are dead and 37.8 million people (range: 34.6–42.3 million)
Cervical Cancer and HPV Z Mike Chirenje MD FRCOG University of Zimbabwe, Department of Obstetrics and Gynecology, Harare, Zimbabwe.
M. Munjoma. Outline Burden of HPV Disease HPV in Zimbabwe HPV Lab Development HPV Protocols.
CANCER MAGNITUDE OF PROBLEM
Jennifer S. Smith University of North Carolina Cervical Cancer-Free America Initiative Overview Changing the Dialogue about Cervical.
Body Weight and Mortality: New Population Based Evidences Body Weight and Mortality: New Population Based Evidences Dongfeng Gu, MD Dongfeng Gu, MD Fu.
Marrakech, Morocco, June 2010 Contents Global burden of cancer Recommendations Regional challenges in cancer prevention and control Regional burden.
World Burden of Cancer Epi 242 Cancer Epidemiology Binh Goldstein, Ph.D. October 7, 2009.
Kenya Field Epidemiology and Laboratory Training Program (KFELTP)
Cervical Cancer in California Janet Bates, MD MPH Research Program Director Research and Surveillance Program California Cancer Registry.
Epidemiology of a Chronic Disease Exercise By Mary Murphy April 2008
Cancer Healthy Kansans 2010 Steering Committee Meeting May 12, 2005.
HIV and AIDS Data Hub for Asia-Pacific 11 HIV and AIDS Data Hub for Asia-Pacific Review in slides India.
TEMPLATE DESIGN © Study on Risk Factors for Cervical Carcinoma at Central Women’s Hospital, Yangon Muyar Soe, Myat Thazin.
00002-E-1 – 1 December 2002 The AIDS Pandemic: an Update on the Numbers and Needs l What are the numbers for 2002? l What are the global and regional trends?
Regional statistics for HIV and AIDS, end of 2010 Region Infected Newly Prev. Deaths Eastern Europe & Central Asia 1.5 million 160,0000.9%90,000 North.
Oncology in midlife and beyond 2013 Oncology in midlife and beyond.
AFRICA HIV/AIDS AIDS DATA SOURCE: UNAIDS 2007 REPORT WORLD HEALTH ORGANIZATION.
Incorporating Multiple Evidence Sources for the Assessment of Breast Cancer Policies and Practices J. Jackson-Thompson, Gentry White, Missouri Cancer Registry,
HIV and AIDS Data Hub for Asia-Pacific Review in slides India.
Study on global AGEing and adult health (SAGE) | 1 |1 | Health of older Ghanaians: Health Risks and Chronic Non-communicable Diseases Dr Alfred E Yawson.
Screening of genital cancers Evidence Based Presented by Dr\ Heba Nour.
Health Statistics and Informatics Non-communicable diseases A global overview.
Acceptability Survey of HPV Vaccine Among Female Sex Workers in Lima, Peru Brandon Brown 1, Cesar Carcamo 2, Maria Valderrama 2, Magaly Blas 2, and Neal.
Midland Cancer Network 2012 Clinical Performance Conference.
© Imperial College LondonPage 1 Understanding the current spread of HIV Geoff Garnett.
Cervical Cancer How We Can Prevent It Dr Quek Swee Chong Himalayan Women’s Health Project 30 August 2014.
Spatial Health Analysis Click to continue. A series of sketch maps and charts are used to present a selection of well-recognised health patterns. These.
Cervical cancer among Asian subgroups in California, Janet Bates, MD MPH California Cancer Registry NAACCR Annual Meeting Denver, Colorado June.
#AIDS2016 Cervical Cancer Prevention in Africa: The Future Nelly Yatich, DrPH University of California San Francisco July 19 th, 2016.
What Factors Influence Early Sexual Debut amongst Youth: Comparative Evidence from Nigeria and India ICASA 2011 Babatunde.O, Temitope.F, Imoisili.A, Alabi.F.
Seroprevalence, prevalence, type and factors associated with HPV infection at multiple sites in young HIV-positive MSM On behalf of the HPV MAPS Research.
University of Rajarata.
به نام خدا.
Timor-Leste Last updated: January 2016.
Cervical Cancer in California
India Last updated: September 2016.
School of Life and Health Sciences, University of Ulster Jordanstown
How do health expenditures vary across the population?
Bhutan.
DPR Korea.
Daffodil International University (DIU), Dhaka Bangladesh
Adolescents (10-19 yr) Last updated: October 2017.
Premalignant Cervical Disease and Delayed HPV Vaccination
3 Mortality Ontario Cancer Statistics 2016 Chapter 3: Mortality.
Nasreen Abdullah, MD, MPH
WHO HIV update July 2018 Global epidemic Global progress and cascade
Spatio-temporal pattern of Mortality in Thailand
Ovarian Cancer Facts and Figures
Dr Paul T Francis, MD Prof. Com Med College of Medicine, Zawia
Cervical Cancer Screening week 11th-18th June 2018
Why is Global Population Increasing?
Bhutan.
Bhutan.
Review in slides DPR Korea
Ovarian Cancer Facts and Figures
Data Hub for Asia-Pacific
Screening to Prevent Invasive Cervical Cancer (Resource-Stratified)
How do health expenditures vary across the population?
Neoplasia of the cervix
HUMAN PAPILLOMA VIRUS and CERVICAL CARCINOMA
Data Hub for Asia-Pacific
Research, Monitoing and Surveillance of Smokeless tobacco use
Demographic and Epidemiological Transition and Cancer in India
Siwei Zhang Rongshou Zheng
Cervical Cancer Surveillance, Screening, and Treatment
Japan Last updated: April 2019.
Presentation transcript:

Epidemiology of cervical cancer in India: Where do we stand today Dr Seema Singhal Department of Obstetrics and Gynaecology AIIMS New Delhi

Cervical cancer disease burden High incidence rates Deterioration of key risk factors Low detection rates Cervical cancer is a major public health problem in India and India bears a huge disease burden because of higher incidence rates lower detection rates and deterioration in the risk factors

Global Incidence and mortality in 2018

India : Major contributor to global burden of cervical cancer If u look at the contribution of India to global burden of cervical cancer

High mortality

Distribution of cervical cancer in India

Distribution of cervical cancer in India and Trends Peak age for cervical cancer incidence in India: 55-59 years. 60 078 cases died

SEARO rgion

Age adjusted Incidence rates per 100 000 women AAIR of CaCx varies widely between and within states

Age adjusted incidence rates of cervix uteri-females (rate per 100,000) in the various population based cancer registries. Cervical cancer is the leading incident cancer site Bangalore 27.3% Chennai 25.4% Guwahati 16.3% Chandigarh 18.4% (NCRP/ HBCR, 2013)

Trends in Cervical Cancer Incidence In Selected Countries (1975-2010)

Annual percentage change for cervix uteri in Indian population based cancer registry All the population-based registries have shown a persistent decline in the age-adjusted rates even in the absence of a control program The mean annual percentage decrease in the average age-adjusted rate ranged from 1.81% to 3.48% among various registries.

In Odisha, CaCx was the second most common cancer, with an increase in incidence of 3.1% from 2001 to 2011. Hussain MA, Pati S, Swain S, et al (2012). Pattern and trends of cancer in Odisha, India: a retrospective study. Asian Pac J Cancer Prev, 13, 6333-36

Time trends of cervical cancer in India Cervical cancer rates among women in the 30–64 age group decreased by 1.8% per year on average but still accounted for 16% of the total female cancer burden. 70-80% 10-15% Satija A. Cervical cancer in India. South Asia centre for chronic disease. Available from: http://sancd.org/uploads/pdf/cervical_cancer.pdf. Accessed February16, 2014.

Prevalence of risk factors for cervical cancer

Risk Factors for ca cervix Cervical cancer rates are higher in rural vs urban populations Sexual Promiscuity Poor Hygiene Lack of awareness of risk factors Low socio economic status, Poor education

HPV agent types

HPV DNA was detected in 95% of invasive cancers (113/119) and 91% of CINs (10/11). A single HPV type was found in 100 women (77%), and mixed infections were found in 23 women (18%). HPV 16 (60%) and HPV 18 (14%) were the most frequent types

High HPV prevalence in India Women without cervical cancer Women with benign cervical cytology World 9-13% India 7.5-16.9% 9.9%-16.6% India (sex workers) Urban slum ( Mumbai) 25% 32.3% India (HIV positive women ) 41.7%-56% North vs South India No significant difference North India (16,45) South India (35) Reference Sreedevi A et al,. Epidemiology of cervical cancer with special focus on India. International Journal of Women’s Health 2015:7 405–414 Bhatla N, Lal N, Bao YP, et al. A meta-analysis of human papilloma- virus type-distribution in women from South Asia: implications for vaccination. Vaccine. 2008;26(23):2811–2817.

High persistence rates A prospective study in Delhi indicated that persistence was higher for high- risk HPV type and the highest rate of persistence was found in types 16, 45, 67, 31, 51, 59. Among the high-risk types, the mean duration of persistence due to HPV-16 was 12.5 months. Prevalence of HPV-18 was greater than that of HPV-16, although HPV-16 was associated more frequently with HSIL. Datta P, Bhatla N, Pandey RM, et al. Type-specific incidence and per- sistence of HPV infection among young women: a prospective study in North India. Asian Pac J Cancer Prev. 2012;13(3):1019–1024.

The coverage Effective coverage: The proportion of eligible women (25-64 years) who report having had a pelvic exam and Pap smear in the past three years Crude coverage : The proportion of women (25-64 years) who report having had a pelvic exam (regardless of when the exam occurred) Data for the UK, the US for 2010; Data for India and China for 2008. Source: International Cancer Screening Network; Gakidou et al, 2008

Poor detection rates USA UK China India Cancer center ( India Metro)

Survival rates In addition, cervical cancer survival rates in India also shows a wide variation ranging from 59.6% in Chennai to 34.5% in Bhopal.

NON- PARTICIPATION

Limitations of available data under-represent the rural, northern and eastern regions of the country. cover only 7% of the Indian population NCRP IARC Globocan mainly derived from the west, south and central of the country mainly derived from the west and south of the country

Conclusion Essential to understand epidemiology of ca cervix in order to prioritize the needs Mortality statistics and trends in cervical cancer are lacking due to inadequate and incomplete informa- tion on deaths. Currently available epidemiological data do indicate quite clearly that HPV infection and associated Ca Cx risk in India is a substantial burden and clear health priority which need to be addressed now………